Ligand validation:2IMD

CXS: 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID

CXS is a Ligand Of Interest in 2IMD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2IMD_CXS_A_312	43%	12%	0.152	0.876	1.83	2.23	1	8	2	0	100%	1
2IMF_CXS_A_312	70%	11%	0.105	0.923	2	2.18	3	7	0	0	100%	0.8
2IME_CXS_A_312	57%	7%	0.133	0.907	2.17	2.71	1	8	1	0	100%	1
6GAL_CXS_M_604	100%	35%	0.043	0.993	1.04	1.52	1	2	0	0	100%	1
3OBL_CXS_B_134	98%	18%	0.058	0.981	2.24	1.29	2	4	0	0	100%	1
1RZL_CXS_A_201	97%	28%	0.067	0.984	1.39	1.49	2	1	0	0	100%	1
7NFZ_CXS_A_401	97%	40%	0.069	0.984	1.1	1.23	1	3	0	0	100%	1
7EMO_CXS_B_203	95%	22%	0.073	0.977	2.06	1.18	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.